Battelle Memorial Institute
Battelle Memorial Institute, doing business as Battelle, is the world's largest independent nonprofit research and development organization. With over 20,000 employees globally, Battelle provides innovative solutions in national security, health, energy, and education sectors. As a nonprofit organization and manufacturer of goods, Battelle frequently provides research, engineering, testing, manufacturing, and information technology services to U.S. federal government agencies through prime and subcontract awards. The organization leverages its extensive scientific resources and technical capabilities across multiple research fields to address complex challenges for government and commercial clients.
Through prime federal contract awards, Battelle has provided the government with a wide range of goods and services across domains like defense, homeland security, health, energy, and transportation. Notable examples include delivering armored vehicles and integrated military systems to the United States Special Operations Command, developing chemical screening and nonclinical study services for the National Institutes of Health, manufacturing aircraft components like the Modular Aerial Spray System for the Department of the Air Force, supporting environmental programs like dredged material testing for the Army Corps of Engineers, and delivering research services for the Defense Advanced Research Projects Agency. Many contracts involve hardware development, laboratory testing, and technical research across chemical, biological, and engineering fields. Battelle serves as both a prime and subcontractor, frequently partnering with specialized manufacturers and technical consultants. Awards span contract types like definitive contracts, purchase orders, and delivery orders issued against IDIQ vehicles like OASIS and GSA Schedules. Few set-asides are specified on these awards issued by the Departments of Defense, Energy, Homeland Security, Health and Human Services, and other major federal agencies and offices.
On the grant side, Battelle has been awarded cooperative agreements by the Department of Energy to support carbon capture and storage technology initiatives, as well as Environmental Protection Agency project grants focused on environmental monitoring and remediation of critical minerals at mining sites. The National Science Foundation has issued cooperative agreements enabling Battelle to operate the National Ecological Observatory Network continental research platform and lead global collaborative networks advancing ecological drought research. These awards provide funding through federal programs like the DOE's Fossil Energy Research and Development, EPA's Consolidated Research/Training/Fellowships, and NSF's Biological Sciences for Battelle to conduct research, field studies, operational maintenance, training, and international partnership activities. Battelle frequently collaborates with universities and other research institutions on these federally-funded studies, combining complementary capabilities to advance scientific knowledge and develop new technologies with potential societal impact.
Battelle holds several major indefinite-delivery indefinite-quantity (IDIQ) contracts providing a broad scope of research, development, testing, and technical support services. These include a $100 million contract for biological animal model and medical countermeasure development through the HHS Biomedical Advanced Research and Development Authority, a $149 million vehicle for manufacturing and nonclinical studies of neurological therapeutic biotechnology products under NIH, and a $100 million EPA contract for chemical screening, review, and evaluation. The Department of Homeland Security awarded Battelle a $95 million single-award IDIQ for research and developmental testing related to transportation security, while the Defense Advanced Research Projects Agency issued an OT IDV valued at $32 million for initiatives like the Foundational Security for Food Systems program. Through these IDIQs, federal agencies gain flexible access to Battelle's extensive scientific resources and technical capabilities across a multitude of research fields.
F125YU6SWK59 541715
Not listed 505 King Ave, Columbus, OH 43201, USA
12/6/01 11/12/25 Leidos, Inc.
Leidos, Inc., operating through its Leidos Services Operating Segment Division and doing business as SAIC, is a global leader in information technology, engineering, and science solutions. The company provides a wide range of products and services to U.S. government agencies, primarily focused on national security, health, and infrastructure. Leidos has secured numerous prime and subcontract awards across federal agencies, leveraging its expertise in areas such as research and development, systems integration, IT modernization, logistics, and specialized equipment procurement. The company's diverse portfolio of work spans defense, intelligence, civil, and health markets, positioning it as a key partner in supporting critical government missions and initiatives.
Through its federal contract awards, Leidos has provided an extensive array of goods and services to various agencies. For the Defense Health Agency, Leidos has supported medical research programs, including studies on traumatic brain injury, psychological health, cancer, and rare diseases. The company has also delivered IT and engineering support for the Department of the Air Force, including F-16 AIS/PSI engineering services. For the Naval Sea Systems Command, Leidos has supplied towed array parts, acoustic hoses, and other specialized naval equipment. The company has supported environmental restoration and remediation efforts for the Army Corps of Engineers, conducting site assessments and feasibility studies for hazardous waste cleanup. Leidos has also provided IT consolidation services for Air Force headquarters, oceanographic support for the Naval Meteorology and Oceanography Command, and litigation support services for the Department of Justice. These contracts demonstrate Leidos' versatility in delivering technical, scientific, and administrative solutions across diverse federal sectors.
While Leidos primarily engages in federal contracting, the company has also participated in some grant-funded research activities. One notable example is a subgrant award from the University of North Dakota for a NASA-funded project titled "Estimating Nocturnal Aerosol Optical Depth Using NASA's Black Marble." This work likely involves leveraging Leidos' expertise in data analysis and earth observation technologies to support scientific research in atmospheric studies. Although grant activities appear to be less prevalent in Leidos' federal engagement compared to contracts, this example showcases the company's capability to contribute to academic and scientific research initiatives in collaboration with universities and federal agencies like NASA.
Leidos holds several significant Indefinite Delivery Vehicles (IDVs) that enable it to provide a broad spectrum of services to federal agencies. The company was awarded a $478 million multiple-award IDC by NASA's Johnson Space Center for the Research, Integration, and Mission Integration Services 2 (REMIS2) program, focusing on spaceflight hardware, software, and mission integration services for the International Space Station. The U.S. Army Corps of Engineers Baltimore District granted Leidos a $200 million IDIQ contract for environmental services related to hazardous, toxic, and radioactive waste projects. The Defense Health Agency awarded Leidos a $102 million single-award IDC for meeting, programmatic, and administrative support services for the Congressionally Directed Medical Research Programs. Additionally, Leidos secured a $45 million multiple-award task order contract from the Army Corps of Engineers for architect-engineer environmental services. These IDVs position Leidos to continue providing critical support across various federal agencies, encompassing areas such as space operations, environmental remediation, medical research, and engineering services.
QLNMVC12KWY3 541715
Not listed 1750 Presidents St Fl 10, Reston, VA 20190, USA
1/5/10 5/30/25 Icon Government And Public Health Solutions, Inc.
Icon Government And Public Health Solutions, Inc. is a global provider of outsourced development services to the pharmaceutical, biotechnology, and medical device industries, specializing in clinical research and offering end-to-end services from compound selection to Phase I-IV clinical trials. It is a foreign-owned, for-profit organization, registered in the System for Award Management (SAM) since 2001.
Icon Government And Public Health Solutions, Inc. has been awarded numerous prime and subcontracts by federal agencies, primarily the Department of Health and Human Services (HHS), Department of Defense (DoD), and National Institutes of Health (NIH). The majority of its contracts involve providing comprehensive clinical trial planning and execution services for medical countermeasures like vaccines, therapeutics, and other products against infectious diseases, chemical/biological threats, and public health emergencies like COVID-19. This includes activities such as protocol development, site selection, regulatory submissions, participant recruitment, data management, quality assurance, and reporting. Icon leverages its network of research sites and team of clinical research associates, scientists, nurses, and project managers to conduct domestic and international trials across all phases. In addition to HHS and DoD, Icon has supported clinical research programs for agencies like the Defense Health Agency and U.S. Army Medical Command. While most awards utilize no set-asides, Icon has participated in socioeconomic set-asides on certain subcontracts.
Icon Government And Public Health Solutions, Inc. holds several prominent indefinite delivery vehicles focused on clinical trials and research support. These include a $400 million Clinical Trials Planning and Execution IDIQ from HHS's Office of the Assistant Secretary for Preparedness and Response enabling rapid task order issuance for medical countermeasure studies, a $545 million Comprehensive and Rapid Response to NIAID Research Programs IDIQ to support the full range of basic research to clinical trials for the NIH's National Institute of Allergy and Infectious Diseases, and a $346 million Early Phase Clinical Trial Units IDIQ providing domestic and international Phase 0 to Phase II trials of investigational infectious disease products for NIAID. Icon was also awarded a $6 million Federal Supply Schedule contract allowing streamlined procurement of professional scientific and technical services across over 70 labor categories. Clients can acquire clinical trial, regulatory, data management, manufacturing, and other services mapped to hourly labor rates under the GSA schedule.
JHJ7HXD5XR47 541715
Not listed 731 Arbor Way #100, Blue Bell, PA 19422, USA
9/27/01 8/28/25 Bioqual, Inc.
Bioqual, Inc. is a fully accredited company that provides state-of-the-art facilities and experienced research scientists, veterinarians, and animal care personnel to support biomedical research. Through federal contracts, the company serves as a prime contractor conducting animal studies, providing lab analysis services, and housing and caring for research animals. As a subcontractor, Bioqual provides housing, care support, and maintenance of nonhuman primates.
Bioqual has received prime contract awards from the National Institutes of Health to conduct vaccine and therapeutic studies related to viruses, provide lab analysis for animal studies, and acquire services for rat and mice treatment studies. Awards have been made under purchase orders and also through task orders issued under indefinite-delivery/indefinite-quantity contracts like the Simian Vaccine Evaluation Units vehicle held by the National Institute of Allergy and Infectious Diseases. Additionally, Bioqual has provided animal housing services as a prime contractor to the Uniformed Services University of the Health Sciences.
As a subcontractor supporting grant awards, Bioqual has provided nonhuman primate procurement, housing, care, dosing, and tissue/biosample collection services. These awards were made under grants focused on HIV cure research, immune system studies, and testing of radiation recovery compounds. Prime grantees have included the University of Maryland Baltimore, Temple University, and the Henry M. Jackson Foundation.
Bioqual holds two indefinite-delivery contracts supporting federal research programs. One is the Simian Vaccine Evaluation Units vehicle allowing for task orders related to primate vaccine studies, care, and housing over a seven year period from the National Institute of Allergy and Infectious Diseases. The other is the Comprehensive and Rapid Response contract providing flexible acquisition of research support services like clinical trials and manufacturing to aid infectious disease research at the National Institute of Allergy and Infectious Diseases.
CK9LGQ7EBNN8 541715
Not listed 9600 Medical Center Dr #101, Rockville, MD 20850, USA
6/8/99 10/3/25